Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | VXRT | Common Stock | Options Exercise | $5.65K | +18.2K | +164.1% | $0.31 | 29.4K | Aug 19, 2022 | Direct | |
transaction | VXRT | Common Stock | Options Exercise | $19.1K | +8K | +27.25% | $2.39 | 37.4K | Aug 19, 2022 | Direct | |
holding | VXRT | Common Stock | 1.5K | Aug 19, 2022 | By Spouse |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | VXRT | Stock Option (right to buy) | Options Exercise | $0 | -18.2K | -50% | $0.00 | 18.2K | Aug 19, 2022 | Common Stock | 18.2K | $0.31 | Direct | F1 |
transaction | VXRT | Stock Option (right to buy) | Options Exercise | $0 | -8K | -12.18% | $0.00 | 57.7K | Aug 19, 2022 | Common Stock | 8K | $2.39 | Direct | F2 |
Id | Content |
---|---|
F1 | The shares subject to this option vest annually over three years from the vesting commencement date of October 25, 2019, the date of the grantee's appointment as a director of Vaxart, Inc. |
F2 | The option is fully vested. |